Our Firm is representing numerous Stryker hip recall clients in this proceeding. We are pleased to see continued progress, and will continue to monitor developments closely.
New York, New York (PRWEB) October 14, 2014
Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) filed on behalf of individuals who were allegedly harmed by Rejuvenate and ABG II Modular-Neck Hip Stems continue to move forward in a multicounty litigation now underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Case Management Order issued on October 8, 2014, the Court’s ongoing medication efforts have resulted in the settlement of an additional case selected for Phase II of the Early Medication program. Of 21 cases chosen for Phases I and II, 20 have been resolved. The Court has also designated 10 Stryker hip recall claims for Phase III, and those cases are now being prepared for mediation. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm is representing numerous Stryker hip recall clients in this proceeding. We are pleased to see continued progress, and will continue to monitor developments closely,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who were allegedly harmed by Stryker’s Rejuvenate and ABG II Modular-Neck Hip Stems.
Stryker Hip Recall
Court records indicate that more than 2,100 Stryker hip lawsuits have been filed in Bergen County Superior Court since the recall was announced. All of these claims similarly allege that the defective nature of the Rejuvenate and ABG II hip stems caused recipients to suffer chronic pain, metallosis, osteolysis, tissue necrosis, and other complications that resulted in premature failure of their hip implant.
In addition to the claims pending in New Jersey, more than 1,700 lawsuits involving similar allegations have been filed in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)
According to the U.S. Food & Drug Administration (FDA), Rejuvenate and ABG II hip stems were named in a worldwide recall on July 6, 2012, after the metal components were found to be vulnerable to fretting and corrosion at the modular-neck junction. According to Stryker, this may place recipients of the implants at risk for adverse local tissue reactions, pain and swelling. The company has recommended that all patients fitted with one of these devices undergo medical testing and imaging screening to ensure their device is performing as intended, even if they have not experienced any symptoms that would suggest otherwise.*
Individuals who were allegedly harmed by Rejuvenate and ABG II hip stems may be eligible to pursue a claim against Stryker. To learn more about the Stryker hip recall, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP